Getinge Ab Class B · OMXSTO:GETI_B
Getinge Ab Class B — SEB Enskilda Nordic Seminar 2011
19 slides from Getinge Ab Class B's conference presentation, Jan 12, 2011
Slide 1: SEB Enskilda Nordic Seminar
SEB ENSKILDA NORDIC SEMINAR Ulf Grunander, CFO Copenhagen 12 January, 2011
Slide 2: A rapidly expanding medical technology company
A rapidly expanding medical technology company Medical Systems Extended Care Infection Control 2 GETINGE GROUP 2011.01.12
Slide 3: Medical Systems
Medical Systems Revenue, SEK billion: 8.5 Revenues by category 50% 50% Capital Equipment Recurring revenues Revenues by geography 30% 38% Western Europe North America 32% RoW 3 GETINGE GROUP 2011.01.12
Slide 4: Extended Care
Extended Care Revenue, SEK billion: 6.2 Revenues by category 40% 60% Capital Equipment Recurring revenues Revenues by geography 11% 31% 58% Western Europe North America RoW 4 GETINGE GROUP 2011.01.12
Slide 5: Infection Control
Infection Control Revenue, SEK billion: 4.7 Revenues by category 35% 39% Capital Equipment Health Care Capital Equipment Life Science 26% Recurring revenues Revenues by geography 20% 48% Western Europe North America 32% RoW 5 GETINGE GROUP 2011.01.12
Slide 6: Getinge has built a competitive business supported by a robust strategy
Getinge has built a competitive business supported by a robust strategy: Global leadership Solution provider Customer relationships 6 GETINGE GROUP 2011.01.12
Slide 7: Global leadership
Global leadership Sterilization no 1 Endoscopic Vessel Harvesting no 1 Disinfection no 1 Beating heart surgery no 2 Anastomosis CABG no 1 Patient Handling no 1 Vascular grafts AAA, TAA no 1 Hygiene Systems no 1 Cardiac Assist IABP no 1 Wound Care/TS no 2 Perfusion no 3 IPC / DVT no 1 Ventilation no
Slide 8: Solution provider
Solution provider Medical Systems Extended Care Infection Control Integrated solutions for Integrated solutions for Integrated infection surgical interventions health care ergonomics control solutions Integrated solutions for cardiac and vascular surgery Life supporting technologies for critical car
Slide 9: Customer relationships
Customer relationships Number of markets 40 Sales companies 92 Sales representatives 1 500 Service engineers 2 350 9 GETINGE GROUP 2011.01.12
Slide 10: Recent structural changes have improved our earnings quality
Recent structural changes have improved our earnings quality • Enhanced exposure to therapeutic disciplines • Reduced dependence on capital equipment sales • Systematic investments in the Group’s sales organisation in emerging economies 10 GETINGE GROUP 2011.01.12
Slide 11: Drivers for profitable growth
DRIVERS FOR PROFITABLE GROWTH
Slide 12: Good growth potential
Good growth potential • Revenue synergies from recent major acquisitions • R&D investments in recent years have significantly increased our available markets • We will continue to invest in proprietary sales channels in emerging economies 12 GETINGE GROUP 2011.01.12
Slide 13: We expect EBITA margins to continue to improve in future years
We expect EBITA margins to continue to improve in future years • New and pending product introductions are associated with higher gross margins • Significant scope for further cost improvements in our supply chain 13 GETINGE GROUP 2011.01.12
Slide 14: External growth
GETINGE GROUP EXTERNAL GROWTH
Slide 15: External Growth
External Growth Reinforcing existing leadership positions • We expect bolt-on acquisitions to add approximately. 2% growth per year. Focus: New technology and geographic expansion Strengthening our capabilities as a solution provider • We expect acquisitions of new and leading product lines that wil
Slide 16: Group financial targets
GETINGE GROUP GROUP FINANCIAL TARGETS
Slide 17: Getinge Group financial targets
Getinge Group financial targets • Pre-tax earnings: Average growth of 15% per year • Long-term organic revenue growth: 5% (next 3-5 years 2% above market, i.e 7%) • Cash conversion: 60-70% of EBITDA • EBITA margin: ~ 20% EBITA margin 2009 Target Medical Systems 19.8% 22% Extended Care 15.5% 19% Infe
Slide 18: 2010 restructuring and earnings expectations
2010 • Additional restructuring activities in the fourth quarter amounting to SEK 108 million, pertaining to the Medical Systems business area. • In total, restructuring expenses for the 2010 fiscal year will amount to SEK 180 million. • Closure of Hirrlingen production unit in Germany to result in
Slide 19: Questions
GETINGE GROUP QUESTIONS